Ani Pharmaceuticals (ANIP) Current Taxes (2013 - 2026)

Ani Pharmaceuticals has disclosed Current Taxes across 13 years of filings, most recently posting $3.5 million for Q2 2026.

• In Q2 2026, Current Taxes rose 7.23% year-over-year to $3.5 million; the TTM figure through Jun 2026 stood at $3.5 million (up 7.23% YoY), while the FY2025 annual figure was $2.2 million, down 60.17% from the prior year.
• Current Taxes came in at $3.5 million for Q2 2026 at Ani Pharmaceuticals, down from $5.3 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $14.2 million in Q1 2025 to a low of $594000.0 in Q3 2023.
• Average Current Taxes over 4 years is $6.0 million, with a median of $5.3 million recorded in 2026.
• Year-over-year, Current Taxes increased 24.43% in 2025 and tumbled 62.67% in 2026.
• Over 4 years, Current Taxes stood at $8.2 million in 2023, then sank by 31.14% to $5.6 million in 2024, then sank by 60.17% to $2.2 million in 2025, then jumped by 57.75% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Current Taxes figures were $3.5 million in Q2 2026, $5.3 million in Q1 2026, and $2.2 million in Q4 2025.